Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Notes Payables (2020 - 2025)

Selectis Health's Notes Payables history spans 8 years, with the latest figure at $775000.0 for Q1 2025.

  • For Q1 2025, Notes Payables changed N/A year-over-year to $775000.0; the TTM value through Mar 2025 reached $775000.0, changed N/A, while the annual FY2023 figure was $900000.0, 500.0% up from the prior year.
  • Notes Payables for Q1 2025 was $775000.0 at Selectis Health, down from $900000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $900000.0 in Q4 2023 and bottomed at $150000.0 in Q4 2021.
  • The 4-year median for Notes Payables is $150000.0 (2021), against an average of $425000.0.
  • The largest annual shift saw Notes Payables skyrocketed 500.0% in 2021 before it changed 0.0% in 2022.
  • A 4-year view of Notes Payables shows it stood at $150000.0 in 2021, then changed by 0.0% to $150000.0 in 2022, then surged by 500.0% to $900000.0 in 2023, then fell by 13.89% to $775000.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Notes Payables are $775000.0 (Q1 2025), $900000.0 (Q4 2023), and $150000.0 (Q4 2022).